Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 5.

Abduljalil, K., Frank, D., Gaedigk, A., Klaassen, T., Tomalik-Scharte, D., Jetter, A., Jaehde, U., Kirchheiner, J. and Fuhr, U. (2010). Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan. Clin. Pharmacol. Ther., 88 (5). S. 643 - 652. NEW YORK: NATURE PUBLISHING GROUP. ISSN 0009-9236

Barnert, A., Kunze, A., Scheid, C., Liekweg, A., Hermes-Moll, K. and Jaehde, U. (2020). Extended medication plan for patients with ORal tumortherapy (EMPORT). Int. J. Clin. Phar,., 42 (1). S. 234 - 236. DORDRECHT: SPRINGER. ISSN 2210-7711

Lenssen, R., Schmitz, K., Griesel, C., Heidenreich, A., Schulz, J. B., Trautwein, C., Marx, N., Fitzner, C., Jaehde, U. and Eisert, A. (2018). Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial. BMC Geriatr., 18. LONDON: BIOMED CENTRAL LTD. ISSN 1471-2318

Suleiman, A. A., Schoettle, J., Jaehde, U., Ullrich, R. and Fuhr, U. (2016). High-pulsed doses of erlotinib for the treatment of non-small-cell lung cancer: A modeling analysis. Naunyn-Schmiedebergs Arch. Pharmacol., 389 (1). S. S70 - 2. NEW YORK: SPRINGER. ISSN 1432-1912

Wilmer, A., Tasar, A., Fleckenstein, K., Hack, C., Beck, H., Liekweg, A., Ruberg, K., Ko, Y. D. and Jaehde, U. (2014). Evaluation of a best-practice model for multiprofessional cancer medication management. Oncol. Res. Treat., 37. S. 103 - 105. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Mar 28 22:29:15 2024 CET.